相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alterations in retinal arteriolar microvascular structure associate with higher treatment burden in patients with diabetic macular oedema: results from a 12-month prospective clinical trial
Soren L. Blindbaek et al.
ACTA OPHTHALMOLOGICA (2020)
Aflibercept Reduces Retinal Hemorrhages and Intravitreal Microvascular Abnormalities But Not Venous Beading Secondary Analysis of the CLARITY Study
Elizabeth Pearce et al.
OPHTHALMOLOGY RETINA (2020)
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway
Francesca Lazzara et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
Faiz I. Shakarchi et al.
CLINICAL OPHTHALMOLOGY (2019)
Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm?
Lihteh Wu et al.
TAIWAN JOURNAL OF OPHTHALMOLOGY (2019)
Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy
Ling Chen et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2018)
Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2018
DIABETES CARE (2018)
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
Sobha Sivaprasad et al.
LANCET (2017)
Diabetes microvascular complications-A clinical update
H. Khalil
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
Ariana M. Levin et al.
CLINICAL OPHTHALMOLOGY (2017)
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy
Cecilia S. Lee et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2017)
Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges
Nikolaos Dervenis et al.
ADVANCES IN THERAPY (2017)
Ranibizumab for High-Risk Proliferative Diabetic Retinopathy: An Exploratory Randomized Controlled Trial
Joao Figueira et al.
OPHTHALMOLOGICA (2016)
Pericyte Loss in Diabetic Retinopathy: Mechanisms and Consequences
Elena Beltramo et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Changes in Retinal Vessel Diameter and Incidence and Progression of Diabetic Retinopathy
Ronald Klein et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy
Jose A. R. Filho et al.
ACTA OPHTHALMOLOGICA (2011)
Inner retinal ischaemia: current understanding and needs for further investigations
Toke Bek
ACTA OPHTHALMOLOGICA (2009)
Correlation of Flicker-Induced and Flow-Mediated Vasodilatation in Patients With Endothelial Dysfunction and Healthy Volunteers
Berthold Pemp et al.
DIABETES CARE (2009)
PANRETINAL PHOTOCOAGULATION COMBINED WITH INTRAVITREAL BEVACIZUMAB IN HIGH-RISK PROLIFERATIVE DIABETIC RETINOPATHY
Won Bin Cho et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Management of diabetic retinopathy - A systematic review
Quresh Mohamed et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Revised formulas for summarizing retinal vessel diameters
MD Knudtson et al.
CURRENT EYE RESEARCH (2003)
分享论文
